Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/03/064944
CTRI/2024/03/064944
Not yet recruiting
Phase 2

A Single-Centric, Single-Arm Pilot Study to Evaluate the Safety and Efficacy of Swasa Kudori Chooranam (SKC) In the Management of Swasa Kaasam (Bronchial Asthma) - SKC

Central Council for Research in Siddha, Ministry of Ayush, Govt. of India0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Central Council for Research in Siddha, Ministry of Ayush, Govt. of India
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Siddha, Ministry of Ayush, Govt. of India

Eligibility Criteria

Inclusion Criteria

  • •1\. Symptoms of dry cough, recurrent attacks of dyspnoea, hoarseness of voice, tightness of chest, profuse sweating, and wheezing
  • •2\. Asthmatic attack due to seasonal changes and allergens
  • •3\. Willing to take radiological investigation and provide blood samples for lab investigation.
  • •4\. FEV1 with 50\-80%

Exclusion Criteria

  • •1\. Asthma associated with COPD
  • •2\. Unstable bronchial asthma or status asthmaticus.
  • •3\. Asthma exacerbation during the past month.
  • •4\. COVID 19 Positive patients (on the time of recruitment).
  • •5\. Tuberculosis, Pneumonia, and Bronchogenic carcinoma
  • •6\. Cardiac, Liver and Renal Diseases.
  • •7\. Participation in another clinical trial within the preceding 90 days of the study starts.
  • •8\. Pregnant and lactating women.
  • •9\. Subjects with a continuing history of Alcohol, Smoking or Drug Abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Treosulfan, fludarabine and cyclophosphamide as a preparative chemotherapy regimen before haploidentical blood or marrow stem cell transplantatioConditioning therapy before haploidentical hematopoietic stem cell transplantationMedDRA version: 22.0Level: LLTClassification code 10059044Term: Allogeneic peripheral hematopoietic stem cell transplantSystem Organ Class: 100000004865Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2021-004730-11-ATMedical University of Vienna30
Completed
Phase 3
A study to assess Efficacy and safety of Ayurvedic Kadha in health and immunity related parameters in mild COVID-19 patients.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/03/032072MARC Laboratories Ltd50
Completed
Not Applicable
A single-center, prospective pilot study to elucidate the fluorescence diagnostic ability of 5-aminolevulinic acid for cholangiocarcinomacholangiocarcinoma
JPRN-UMIN000025915Okayama University Hospital20
Recruiting
Phase 2
The availability study of tissue oxygenation monitor in pharyngeal and tracheal mucosaCancer or severe aspiration condition requiring total laryngectomy
JPRN-jRCTs042220151Mukaigawa Takashi20
Recruiting
Phase 1
A clinical trial to evaluate the safety and efficacy of the pluripotent stem cell accumulating device (BSM1) and treatment of diabetic foot ulcers using BiiosheetsDiabetic foot ulcers unhealed with standard treatment or requiring extra-resection of proximal sites
JPRN-jRCT2032230318Higashita Ryuji10